Micronuclear DNA or chromatin bridges were shown to trigger an IFN response in cancer cells treated with genotoxic drugs (39, 40), and TREX1 was reported to limit cGAS activation in genetically unstable cells by degradation of micronuclear DNA (41). Here, TREX1 is linked to cancer.